• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本慢性肾脏病患者的血压控制:一项全国队列的基线调查。

Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.

机构信息

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

出版信息

Am J Hypertens. 2012 Mar;25(3):342-7. doi: 10.1038/ajh.2011.217. Epub 2011 Nov 17.

DOI:10.1038/ajh.2011.217
PMID:22089103
Abstract

BACKGROUND

Hypertension is a key risk factor for adverse renal outcomes in chronic kidney disease (CKD), and strict blood pressure control is recommended to halt its progression. This study assessed blood pressure control in the Japanese CKD population.

METHODS

We used a nationwide database of 250,130 subjects (aged 20-88), including 45,845 CKD subjects (18.3%), participated in an annual health check, "The Specific Health Check and Guidance in Japan," and examined the relationship between CKD status and blood pressure. Blood pressures were measured in sitting position by trained staff, and target blood pressure for CKD subjects was defined as systolic (SBP)/diastolic blood pressure (DBP) <130/80 mm Hg.

RESULTS

In total population, CKD subjects had a higher prevalence of hypertension (58.0% vs. 41.8%, P < 0.001) and a higher proportion with antihypertensive medication (42.4% vs. 26.7%, P < 0.001), compared with non-CKD subjects. The proportion of subjects achieving target blood pressure was significantly lower among total CKD subjects than among total non-CKD subjects (34.6% vs. 43.8%, P ≤ 0.001). Among CKD subjects, these proportions were especially low in those with stage 4-5 (24.3-27.5%), those on antihypertensive medication (21.6%) and those with proteinuria ≥2± (21.3%). Logistic regression analysis showed that independent factors for high-blood pressure in CKD subjects were age, male gender, alcohol consumption, nonsmoking, diabetes, dyslipidemia, obesity, proteinuria, and antihypertensive medication.

CONCLUSIONS

Blood pressure control was inadequate in the majority of Japanese CKD subjects, despite antihypertensive treatment. More aggressive efforts to achieve target blood pressures among CKD subjects are recommended.

摘要

背景

高血压是慢性肾脏病(CKD)不良肾脏结局的一个关键危险因素,建议严格控制血压以阻止其进展。本研究评估了日本 CKD 人群的血压控制情况。

方法

我们使用了一个包含 250130 名受试者(年龄 20-88 岁)的全国性数据库,其中包括 45845 名 CKD 受试者(18.3%),他们参加了年度健康检查“日本特定健康检查和指导”,并检查了 CKD 状态与血压之间的关系。血压由经过培训的工作人员在坐姿下测量,CKD 受试者的目标血压定义为收缩压(SBP)/舒张压(DBP)<130/80mmHg。

结果

在总人群中,与非 CKD 受试者相比,CKD 受试者高血压的患病率更高(58.0% vs. 41.8%,P<0.001),服用降压药物的比例也更高(42.4% vs. 26.7%,P<0.001)。与非 CKD 受试者相比,总 CKD 受试者中达到目标血压的患者比例明显更低(34.6% vs. 43.8%,P≤0.001)。在 CKD 受试者中,这些比例在 4-5 期(24.3-27.5%)、服用降压药物(21.6%)和蛋白尿≥2+(21.3%)的患者中尤其低。Logistic 回归分析显示,CKD 患者高血压的独立因素是年龄、男性、饮酒、不吸烟、糖尿病、血脂异常、肥胖、蛋白尿和服用降压药物。

结论

尽管进行了降压治疗,但大多数日本 CKD 患者的血压控制仍不理想。建议对 CKD 患者更积极地努力实现目标血压。

相似文献

1
Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.日本慢性肾脏病患者的血压控制:一项全国队列的基线调查。
Am J Hypertens. 2012 Mar;25(3):342-7. doi: 10.1038/ajh.2011.217. Epub 2011 Nov 17.
2
Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.老年慢性肾脏病患者家庭血压控制对肾脏和心血管结局的预后意义。
Hypertens Res. 2009 Dec;32(12):1123-9. doi: 10.1038/hr.2009.165. Epub 2009 Oct 9.
3
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.肥胖对非糖尿病慢性肾脏病进展的影响:一项回顾性队列研究。
Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.
4
Treatment of hypertension in chronic kidney disease.慢性肾脏病高血压的治疗
Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016.
5
CKD awareness and blood pressure control in the primary care hypertensive population.在基层医疗机构的高血压患者中提高对慢性肾脏病的认识和血压控制水平。
Am J Kidney Dis. 2011 Jan;57(1):71-7. doi: 10.1053/j.ajkd.2010.08.022. Epub 2010 Nov 17.
6
Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt.埃及慢性肾脏病信息、预防与治疗(EGIPT-CKD)项目:埃及慢性肾脏病患者亲属中微量白蛋白尿的患病率及危险因素
Saudi J Kidney Dis Transpl. 2011 Sep;22(5):1055-63.
7
The MAURO study: baseline characteristics and compliance with guidelines targets.MAURO 研究:基线特征和对指南目标的依从性。
J Nephrol. 2012 Nov-Dec;25(6):1081-90. doi: 10.5301/jn.5000239.
8
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.缬沙坦联合氢氯噻嗪与氨氯地平单药治疗对伴有其他心血管危险因素的高血压患者的疗效及耐受性比较:VAST研究
Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.
9
Hypertension awareness, treatment, and control in chronic kidney disease.慢性肾脏病中的高血压知晓率、治疗及控制情况
Am J Med. 2008 Apr;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025.
10
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.

引用本文的文献

1
Combined traditional Chinese medicine and anti-hypertensive treatments for renal hypertension: A network meta-analysis and systematic review.中药联合抗高血压治疗肾性高血压:网状 Meta 分析和系统评价。
Medicine (Baltimore). 2024 Oct 4;103(40):e39793. doi: 10.1097/MD.0000000000039793.
2
Improving Blood Pressure Control Using Digital Communication Methods in Serbia.在塞尔维亚使用数字通信方法改善血压控制
Diagnostics (Basel). 2022 Apr 6;12(4):914. doi: 10.3390/diagnostics12040914.
3
Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries.
各国肾脏病诊疗实践中对《改善全球肾脏病预后(KDIGO)慢性肾脏病指南》的遵循情况。
Kidney Int Rep. 2020 Dec 17;6(2):437-448. doi: 10.1016/j.ekir.2020.11.039. eCollection 2021 Feb.
4
Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan.代谢综合征对日本特定健康检查和指导计划参与者死亡率的影响。
Intern Med. 2020 Nov 1;59(21):2671-2678. doi: 10.2169/internalmedicine.4975-20. Epub 2020 Jul 14.
5
Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort.根据基础肾脏疾病控制慢性肾脏病患者的血压:福岛慢性肾脏病队列研究。
Clin Exp Nephrol. 2020 May;24(5):427-434. doi: 10.1007/s10157-019-01838-y. Epub 2019 Dec 26.
6
Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.2017 年美国心脏病学会/美国心脏协会血压指南对亚洲下一个血压指南的影响。
Curr Hypertens Rep. 2019 Jan 10;21(1):2. doi: 10.1007/s11906-019-0906-2.
7
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study.慢性肾脏病中的血压控制:来自德国慢性肾脏病(GCKD)研究的横断面分析。
PLoS One. 2018 Aug 20;13(8):e0202604. doi: 10.1371/journal.pone.0202604. eCollection 2018.
8
Agreement between home and ambulatory blood pressure measurement in non-dialysed chronic kidney disease patients in Cameroon.喀麦隆未透析慢性肾脏病患者家庭血压与动态血压测量之间的一致性
Pan Afr Med J. 2018 Jan 24;29:71. doi: 10.11604/pamj.2018.29.71.12078. eCollection 2018.
9
Dipstick proteinuria and all-cause mortality among the general population.普通人群中的试纸法蛋白尿与全因死亡率
Clin Exp Nephrol. 2018 Dec;22(6):1331-1340. doi: 10.1007/s10157-018-1587-x. Epub 2018 Jun 5.
10
Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.2008 - 2012年日本特定健康检查与指导项目筛查对象的死亡风险
Clin Exp Nephrol. 2017 Dec;21(6):978-985. doi: 10.1007/s10157-017-1392-y. Epub 2017 Mar 3.